THERANEXUS
About the company
Theranexus is a French biopharmaceutical company discovering and developing treatments to meet the needs of patients with rare neurological disorders.
About the solution
Their lead asset is an exclusive first liquid formulation of miglustat developed in Niemann Pick C and Batten diseases
Key information
– Therapeutic areas: Central nervous system (CNS)
– Based in: Lyon (FRANCE)
– Employees: 11 -50
– Created in: 2013
